Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies

High Tide

Market Cap: CA$275.9m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Cresco Labs

Market Cap: CA$508.6m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Decibel Cannabis

Market Cap: CA$63.5m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Bausch Health Companies

Market Cap: CA$1.8b

Operates as a diversified specialty pharmaceutical and medical device company.

Planet 13 Holdings

Market Cap: CA$60.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Curaleaf Holdings

Market Cap: CA$3.6b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Aurora Cannabis

Market Cap: CA$235.4m

Engages in the production, distribution, and sale of cannabis products in Canada and internationally.

MariMed

Market Cap: CA$27.0m

Engages in cultivation, production, and selling of branded cannabis products in the United States.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Jushi Holdings

Market Cap: CA$92.9m

Engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States.

Green Thumb Industries

Market Cap: CA$2.3b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Medexus Pharmaceuticals

Market Cap: CA$158.3m

Operates as a pharmaceutical company in Canada and the United States.

Verano Holdings

Market Cap: CA$630.4m

Engages in the cannabis business in the United States.

TerrAscend

Market Cap: CA$326.4m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Organigram Global

Market Cap: CA$196.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Rubicon Organics

Market Cap: CA$29.7m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Auxly Cannabis Group

Market Cap: CA$258.0m

Operates as a consumer-packaged goods company in the cannabis products market in Canada.

SOL Global Investments

Market Cap: CA$1.1m

A private equity firm specializing in emerging growth.

Vext Science

Market Cap: CA$55.7m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

Novartis

Market Cap: CA$227.5b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Cipher Pharmaceuticals

Market Cap: CA$432.0m

Operates as a specialty pharmaceutical company in Canada.

Avant Brands

Market Cap: CA$8.0m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Vireo Growth

Market Cap: CA$655.0m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

1933 Industries

Market Cap: CA$2.6m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Thermo Fisher Scientific

Market Cap: CA$189.6b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

Gilead Sciences

Market Cap: CA$168.6b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Fennec Pharmaceuticals

Market Cap: CA$358.1m

Operates as a commercial stage biopharmaceutical company in the United States.

Pfizer

Market Cap: CA$137.1b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Roche Holding

Market Cap: CA$267.2b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Eli Lilly

Market Cap: CA$1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

CordovaCann

Market Cap: CA$3.6m

Engages in the provision of services and investment capital to the processing, production, and retail vertical markets of the cannabis industry in Canada and United States.

Sanofi

Market Cap: CA$90.5b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Cybin

Market Cap: CA$386.2m

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.

BioSyent

Market Cap: CA$167.5m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Amgen

Market Cap: CA$198.6b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.